Trump Drug Pricing Deals Expand As Johnson & Johnson Joins TrumpRx Platform
Johnson & Johnson will add four prescription drugs to the Trump administration's TrumpRx website starting Friday, joining the low-cost platform and securing an exemption from the president's tariff program in exchange for lower prices.
Under the voluntary deal, J&J will market metformin and three other medicines on TrumpRx and offer Medicaid access to more affordable prescriptions. The company's move is reported to more than double the number of drugs on TrumpRx. Those discounts are aimed at people who are uninsured or whose insurance does not cover a drug and who must pay the full list price. As part of its broader engagement with the administration, J&J previously pledged $55 billion in investments in research and production facilities in Pennsylvania and North Carolina.
The expansion follows a multi-year push by the administration to tie U.S. drug prices to lower international rates and pressure manufacturers into deals. After a 2025 executive order aimed at enforcing most-favored-nation pricing, the White House cut deals with Pfizer and AstraZeneca to lower Medicaid prices and list drugs on TrumpRx. TrumpRx launched on February 5, 2026, with an initial slate of discounted brand-name medicines. By March the program had roughly 54 drugs, and the administration imposed 100% tariffs on imported patented pharmaceuticals on April 2 to push more companies into pricing talks.
The announcement drew mixed reactions online, with supporters praising bigger price cuts and critics warning that big drugmakers still posted massive profits while offering limited discounts. The inclusion of metformin is notable because about 14.7% of the U.S. population has diabetes, and many of those patients use metformin to treat type 2 diabetes. Roughly 27 million Americans lack insurance, making them the primary group that could use TrumpRx coupons and discounted list prices.
đ Relevant Data
TrumpRx, launched on February 5, 2026, initially featured approximately 43 discounted brand-name drugs, expanding to 54 by March 2026, providing coupons for most-favored-nation pricing to uninsured or cash-paying patients.
TrumpRx - Wikipedia â Wikipedia
On April 2, 2026, President Trump imposed tariffs on imported patented pharmaceutical products to bolster national security and strengthen U.S. supply chains, from which Johnson & Johnson received an exemption as part of the deal.
Fact Sheet: President Donald J. Trump Bolsters National Security and Strengthens U.S. Supply Chains by Imposing Tariffs on Patented Pharmaceutical Products â The White House
As of 2026, approximately 27 million Americans lack health insurance, representing the primary group eligible for TrumpRx discounts.
Uninsured Americans 2026: 27M Without Coverage, ACA Subsidy Challenges â MoneyGeek
In 2026, approximately 14.7% of the U.S. population has diabetes, with about 1.2 million new cases diagnosed each year, predominantly Type 2 diabetes treatable with medications like metformin.
Diabetes statistics 2026 â SingleCare
đ Key Facts
- Johnson & Johnson will begin marketing four prescription drugs on the Trump administration's TrumpRx website starting Friday (source report date: 2026-04-24).
- One of the initial J&J drugs to appear on TrumpRx is metformin, a common Type 2 diabetes medication.
- The addition of J&J's four drugs more than doubles the number of medications featured on the TrumpRx low-cost site.
- TrumpRx listings are limited to patients who are uninsured or whose insurance does not cover the drug and who pay the full list price.
- The J&J agreement is structured as a voluntary deal in which J&J will lower costs by providing Medicaid access to affordable prescriptions and marketing on TrumpRx in exchange for an exemption from the president's tariff agenda.
- As part of its broader engagement with the administration, Johnson & Johnson previously agreed to invest $55 billion in research and production facilities in Pennsylvania and North Carolina.
đ° Source Timeline (2)
Follow how coverage of this story developed over time
- Johnson & Johnson will begin marketing four medications on the Trump administration's TrumpRx website starting Friday.
- The J&J deal is structured as a voluntary agreement to lower costs by providing Medicaid access to affordable prescriptions and marketing on TrumpRx in exchange for exemption from the president's tariff agenda.
- One of the initial J&J drugs on TrumpRx will be metformin, a common Type 2 diabetes prescription.
- The addition of J&J drugs more than doubles the number of medications featured on the TrumpRx low-cost site and is limited to patients who are uninsured or whose insurance does not cover the drug and who pay full list price.
- Johnson & Johnson previously agreed to invest $55 billion in research and production facilities in Pennsylvania and North Carolina as part of its broader engagement with the administration.